LAMEA Skin Cancer Diagnostics Market Size, Share & Trends Analysis Report By Type (Non-Melanoma and Melanoma), By Test Type (Skin Biopsy, Imaging Tests, Dermatoscopy, Lymph Node Biopsy, and Others), ByEnd-use, By Country and Growth Forecast, 2024 - 2031

The Latin America, Middle East and Africa Skin Cancer Diagnostics Market would witness market growth of 7.6% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Skin Cancer Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $267.1 million by 2031. The Argentina market is showcasing a CAGR of 8.3% during (2024 - 2031). Additionally, The UAE market is registering a CAGR of 6.6% during (2024 - 2031).

The skin cancer diagnostics market has become a critical segment of the broader healthcare industry as a result of the increasing prevalence of skin cancer. As one of the most common forms of cancer, skin cancer includes various types, primarily categorized into melanoma and non-melanoma skin cancers (NMSC).

Additionally, the increasing incidence of these cancers has driven significant advancements in diagnostic technologies and methods, transforming the landscape of dermatological care. This market is influenced by many factors, ranging from demographic shifts and lifestyle changes to technological innovations and healthcare policies.

In numerous LAMEA countries, the prevalence of cutaneous cancer is increasing. This is attributed to increased sun exposure due to outdoor lifestyles and occupations and a lack of public awareness about skin cancer prevention. This rise in cases fuels the need for accessible and efficient diagnostic tools. In Brazil, the rising incidence of skin cancer is closely linked to increasing awareness and the implementation of extensive screening programs. According to the World Cancer Research Fund, Brazil reported 9,676 new cases of skin cancer in 2022.

Free Valuable Insights: The Worldwide Skin Cancer Diagnostics Market is Projected to reach USD 12.8 Billion by 2031, at a CAGR of 5.3%

Based on Type, the market is segmented into Non-Melanoma and Melanoma. Based on Test Type, the market is segmented into Skin Biopsy, Imaging Tests, Dermatoscopy, Lymph Node Biopsy, and Others. Based on End-use, the market is segmented into Hospital & Clinics, Laboratories, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

• Castle Biosciences, Inc.
• Bausch Health Companies, Inc. (DermTech, Inc.)
• Canfield Scientific, Inc.
• DermaSensor, Inc.
• F.Hoffmann-La Roche Ltd.
• NeoGenomics, Inc.
• Quest Diagnostics Incorporated.
• Digital Diagnostics, Inc. (3Derm Systems, Inc.)
• FotoFinder Systems GmbH
• Veriskin Inc

LAMEA Skin Cancer Diagnostics Market Report Segmentation

By Type

• Non-Melanoma
• Melanoma

By Test Type

• Skin Biopsy
• Imaging Tests
• Dermatoscopy
• Lymph Node Biopsy
• Others

By End-use

• Hospital & Clinics
• Laboratories
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Skin Cancer Diagnostics Market, by Type
1.4.2 LAMEA Skin Cancer Diagnostics Market, by Test Type
1.4.3 LAMEA Skin Cancer Diagnostics Market, by End-use
1.4.4 LAMEA Skin Cancer Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Skin Cancer Diagnostics Market by Type
4.1 LAMEA Non-Melanoma Market by Country
4.2 LAMEA Melanoma Market by Country

Chapter 5. LAMEA Skin Cancer Diagnostics Market by Test Type
5.1 LAMEA Skin Biopsy Market by Country
5.2 LAMEA Imaging Tests Market by Country
5.3 LAMEA Dermatoscopy Market by Country
5.4 LAMEA Lymph Node Biopsy Market by Country
5.5 LAMEA Others Market by Country

Chapter 6. LAMEA Skin Cancer Diagnostics Market by End-use
6.1 LAMEA Hospital & Clinics Market by Country
6.2 LAMEA Laboratories Market by Country
6.3 LAMEA Others Market by Country

Chapter 7. LAMEA Skin Cancer Diagnostics Market by Country
7.1 Brazil Skin Cancer Diagnostics Market
7.1.1 Brazil Skin Cancer Diagnostics Market by Type
7.1.2 Brazil Skin Cancer Diagnostics Market by Test Type
7.1.3 Brazil Skin Cancer Diagnostics Market by End-use
7.2 Argentina Skin Cancer Diagnostics Market
7.2.1 Argentina Skin Cancer Diagnostics Market by Type
7.2.2 Argentina Skin Cancer Diagnostics Market by Test Type
7.2.3 Argentina Skin Cancer Diagnostics Market by End-use
7.3 UAE Skin Cancer Diagnostics Market
7.3.1 UAE Skin Cancer Diagnostics Market by Type
7.3.2 UAE Skin Cancer Diagnostics Market by Test Type
7.3.3 UAE Skin Cancer Diagnostics Market by End-use
7.4 Saudi Arabia Skin Cancer Diagnostics Market
7.4.1 Saudi Arabia Skin Cancer Diagnostics Market by Type
7.4.2 Saudi Arabia Skin Cancer Diagnostics Market by Test Type
7.4.3 Saudi Arabia Skin Cancer Diagnostics Market by End-use
7.5 South Africa Skin Cancer Diagnostics Market
7.5.1 South Africa Skin Cancer Diagnostics Market by Type
7.5.2 South Africa Skin Cancer Diagnostics Market by Test Type
7.5.3 South Africa Skin Cancer Diagnostics Market by End-use
7.6 Nigeria Skin Cancer Diagnostics Market
7.6.1 Nigeria Skin Cancer Diagnostics Market by Type
7.6.2 Nigeria Skin Cancer Diagnostics Market by Test Type
7.6.3 Nigeria Skin Cancer Diagnostics Market by End-use
7.7 Rest of LAMEA Skin Cancer Diagnostics Market
7.7.1 Rest of LAMEA Skin Cancer Diagnostics Market by Type
7.7.2 Rest of LAMEA Skin Cancer Diagnostics Market by Test Type
7.7.3 Rest of LAMEA Skin Cancer Diagnostics Market by End-use

Chapter 8. Company Profiles
8.1 Castle Biosciences, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.1.4.2 Acquisition and Mergers:
8.1.5 SWOT Analysis
8.2 Bausch Health Companies, Inc.(DermTech, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Canfield Scientific, Inc.
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 DermaSensor, Inc.
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Neogenomics, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Quest Diagnostics Incorporated
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Recent strategies and developments:
8.7.4.1 Partnerships, Collaborations, and Agreements:
8.7.4.2 Acquisition and Mergers:
8.7.5 SWOT Analysis
8.8 Digital Diagnostics, Inc.(3Derm Systems, Inc.)
8.8.1 Company Overview
8.9 FotoFinder Systems GmbH
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. VERISKIN INC.
8.10.1 Company Overview
8.10.2 SWOT Analysis

TABLE 1 LAMEA Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 2 LAMEA Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 3 LAMEA Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 4 LAMEA Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 5 LAMEA Non-Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 6 LAMEA Non-Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 7 LAMEA Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 8 LAMEA Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 9 LAMEA Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 10 LAMEA Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 11 LAMEA Skin Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 12 LAMEA Skin Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 13 LAMEA Imaging Tests Market by Country, 2020 - 2023, USD Million
TABLE 14 LAMEA Imaging Tests Market by Country, 2024 - 2031, USD Million
TABLE 15 LAMEA Dermatoscopy Market by Country, 2020 - 2023, USD Million
TABLE 16 LAMEA Dermatoscopy Market by Country, 2024 - 2031, USD Million
TABLE 17 LAMEA Lymph Node Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 18 LAMEA Lymph Node Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 19 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 20 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 21 LAMEA Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 22 LAMEA Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 23 LAMEA Hospital & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 24 LAMEA Hospital & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 25 LAMEA Laboratories Market by Country, 2020 - 2023, USD Million
TABLE 26 LAMEA Laboratories Market by Country, 2024 - 2031, USD Million
TABLE 27 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 28 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 29 LAMEA Skin Cancer Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 30 LAMEA Skin Cancer Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 31 Brazil Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 32 Brazil Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 33 Brazil Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 34 Brazil Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 35 Brazil Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 36 Brazil Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 37 Brazil Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 38 Brazil Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 39 Argentina Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 40 Argentina Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 41 Argentina Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 42 Argentina Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 43 Argentina Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 44 Argentina Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 45 Argentina Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 46 Argentina Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 47 UAE Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 48 UAE Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 49 UAE Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 50 UAE Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 51 UAE Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 52 UAE Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 53 UAE Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 54 UAE Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 55 Saudi Arabia Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 56 Saudi Arabia Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 57 Saudi Arabia Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 58 Saudi Arabia Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 59 Saudi Arabia Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 60 Saudi Arabia Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 61 Saudi Arabia Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 62 Saudi Arabia Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 63 South Africa Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 64 South Africa Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 65 South Africa Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 66 South Africa Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 67 South Africa Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 68 South Africa Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 69 South Africa Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 70 South Africa Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 71 Nigeria Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 72 Nigeria Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 73 Nigeria Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 74 Nigeria Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 75 Nigeria Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 76 Nigeria Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 77 Nigeria Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 78 Nigeria Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 79 Rest of LAMEA Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 80 Rest of LAMEA Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 81 Rest of LAMEA Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 82 Rest of LAMEA Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 83 Rest of LAMEA Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 84 Rest of LAMEA Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 85 Rest of LAMEA Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 86 Rest of LAMEA Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 87 Key Information – Castle Biosciences, Inc.
TABLE 88 key information – Bausch Health Companies, Inc.
TABLE 89 Key Information – Canfield Scientific, Inc.
TABLE 90 Key Information – Dermasensor, Inc.
TABLE 91 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 92 Key Information – neogenomics, inc.
TABLE 93 Key information – Quest Diagnostics Incorporated
TABLE 94 Key Information – Digital Diagnostics, Inc.
TABLE 95 Key Information – FotoFinder Systems GmbH
TABLE 96 Key Information – Veriskin Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Skin Cancer Diagnostics Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Skin Cancer Diagnostics Market
FIG 4 Porter’s Five Forces Analysis – Skin Cancer Diagnostics Market
FIG 5 LAMEA Skin Cancer Diagnostics Market share by Type, 2023
FIG 6 LAMEA Skin Cancer Diagnostics Market share by Type, 2031
FIG 7 LAMEA Skin Cancer Diagnostics Market by Type, 2020 - 2031, USD Million
FIG 8 LAMEA Skin Cancer Diagnostics Market share by Test Type, 2023
FIG 9 LAMEA Skin Cancer Diagnostics Market share by Test Type, 2031
FIG 10 LAMEA Skin Cancer Diagnostics Market by Test Type, 2020 - 2031, USD Million
FIG 11 LAMEA Skin Cancer Diagnostics Market share by End-use, 2023
FIG 12 LAMEA Skin Cancer Diagnostics Market share by End-use, 2031
FIG 13 LAMEA Skin Cancer Diagnostics Market by End-use, 2020 - 2031, USD Million
FIG 14 LAMEA Skin Cancer Diagnostics Market share by Country, 2023
FIG 15 LAMEA Skin Cancer Diagnostics Market share by Country, 2031
FIG 16 LAMEA Skin Cancer Diagnostics Market by Country, 2020 - 2031, USD Million
FIG 17 SWOT analysis: Castle Biosciences, Inc.
FIG 18 SWOT Analysis: Bausch Health Companies, Inc.
FIG 19 SWOT Analysis: Canfield Scientific, Inc.
FIG 20 SWOT analysis: DermaSensor, Inc.
FIG 21 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 22 Swot Analysis: Neogenomics, Inc.
FIG 23 SWOT Analysis: Quest Diagnostics Incorporated
FIG 24 SWOT Analysis: FotoFinder Systems GmbH
FIG 25 SWOT analysis: VERISKIN INC.